MiNK Therapeutics, Inc.
INKT
$11.90
$0.453.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 26.18% | 0.88% | -5.64% | -59.84% | -56.85% |
| Total Depreciation and Amortization | -26.02% | -28.94% | -28.39% | -30.19% | 8.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.93% | -19.59% | -97.08% | 170.67% | 225.89% |
| Change in Net Operating Assets | -49.70% | -41.91% | 2,293.46% | 1,868.33% | 1,566.46% |
| Cash from Operations | -32.73% | -29.21% | -20.03% | 68.57% | 31.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 273,140.00% | 525,050.00% | -- | 199,101.47% | -99.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 273,140.00% | -350,233.33% | -- | 199,101.47% | -99.99% |
| Foreign Exchange rate Adjustments | -112.74% | 33.33% | 5.53% | -285.19% | 182.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.72% | -185.72% | 47.41% | 522.03% | -144.41% |